US equities |
SPCX $167.42 ▲+5.32% NVDA $236.29 ▲+1.00% MU $1,066.38 ▼-0.79% TSLA $378.45 ▲+2.12% MSFT $526.38 ▲+1.71% SNDK $1,710.64 ▼-0.54% INTC $117.37 ▼-1.64% META $744.33 ▲+2.23%
FinancialContent

Articles published by Veradermics, Inc.

News headline image
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss
From Veradermics, Inc.
Via Business Wire
Tickers MANE